WUN101-01: First in Human Human (FIH) Phase 1 Study of WU-NK-101 (W-NK1) in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Amanda F. Cashen, MHD Monzr M. Al Malki, Don A. Stevens, Lori Muffly, Natasha Edwin, Edward Abadir, Peter Tan, Sandrine Niyongere, Ashish Bajel, Laura Arthur, Nitin Mahajan, Ben Capoccia, Tom Leedom, Basia Muz, Kristann Magee, Ouiam Bakkacha, Justo L. Gonzalez, Deborah Masters, Stephen Moran, Eileen McNulty, Angela Pannunzio, Jayakumar Vadakekolathu, Tony Wu, Maria del Rosario, Preeta Dasgupta, Michael Munroe, Laura Simpson, Melissa M Berrien-Elliott, John Muth, Sergio Rutella, Jan K Davidson-Moncada, Todd A Fehniger
Institutions: Washington University in St. Louis, City Of Hope National Medical Center, Norton Healthcare, Stanford Medicine, Stanford University, Providence Portland Medical Center, Royal Prince Alfred Hospital, Royal Perth Hospital, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Nottingham Trent University, Saint Louis University
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039566